John Blankenship
NPI 1730160177 · Specialist · Athens, GA
Enrolled with Medicare as Practitioner - Urology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1730160177
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Sex
- Male
- Sole proprietor
- No
- License
- 049529 (GA)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
20,261 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Ketone Bodies Analysis, Quantitative82010 | 1,975 | $8 |
| Glucose (sugar) Level on Body Fluid82945 | 1,975 | $4 |
| Chemical Analysis Using Spectrophotometry (light)84311 | 1,975 | $8 |
| Urinalysis for Bacteria81007 | 1,965 | $29 |
| Urine Microalbumin (protein) Level82043 | 1,942 | $6 |
| Total Protein Level, Urine84156 | 1,941 | $4 |
| Urine Hemoglobin Level83069 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 51 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Tamsulosin Hcl | 943 | 348 |
| Finasteride | 760 | 230 |
| Alfuzosin Hclbrand: Alfuzosin Hcl Er | 677 | 198 |
| Oxybutynin Chloridebrand: Oxybutynin Chloride Er | 500 | 183 |
| Ciprofloxacin Hcl | 414 | 344 |
| Mirabegronbrand: Myrbetriq | 354 | 100 |
| Hydrocodone/Acetaminophen |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$2,070 across 71 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-11-11
- Last updated
- 2020-11-05
- Certified
- 2020-11-05
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.